NAACCR Item #3921: Residual Tumor Volume Post Cytoreduction
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.residualTumVolPostCytoreduction
Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.
Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.
|00||No gross residual tumor nodules|
|50||Residual tumor nodule(s) 1 centimeter (cm) or less|
|60||Residual tumor nodule(s) greater than 1 cm|
|70||Macroscopic residual tumor nodule(s), size not stated|
|80||Procedure described as optimal debulking and size of residual tumor nodule(s) not given|
|97||No cytoreductive surgery performed|
|98||Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 98 will result in an edit error.)
|99||Not documented in medical record
Residual tumor status after cytoreductive surgery not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.